Does a history of cannabis use influence onset and course of schizophrenia?

Allebeck, Peter; Gunnarsson, Tove; Lundin, Andreas; Löfving, Sofia; Dal, Henrik; Zammit, Stanley

Allebeck, Peter; Gunnarsson, Tove; Lundin, Andreas; Löfving, Sofia; Dal, Henrik; Zammit, Stanley.

Afiliación

Allebeck P; Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
Gunnarsson T; Department of Clinical Neurosciences, Karolinska Institutet, Stockholm, Sweden.
Lundin A; Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
Löfving S; Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
Dal H; Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
Zammit S; Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.

Acta Psychiatr Scand ; 147(6): 614-622, 2023 06.

Article en En | MEDLINE | ID: mdl-37094811

Asunto(s)

Cannabis; Abuso de Marihuana; Trastornos Psicóticos; Esquizofrenia; Adolescente; Humanos; Esquizofrenia/diagnóstico; Abuso de Marihuana/complicaciones; Abuso de Marihuana/epidemiología; Trastornos Psicóticos/diagnóstico; Causalidad

Palabras clave

cannabis; clinical course; psychosis; schizophrenia; symptoms

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trastornos Psicóticos / Esquizofrenia / Cannabis / Abuso de Marihuana Tipo de estudio: Diagnostic_studies / Guideline Límite: Adolescent / Humans Idioma: En Revista: Acta Psychiatr Scand Año: 2023 Tipo del documento: Article País de afiliación: Suecia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google